JPRN-UMIN000010818已完成未知
Evaluation of combinational effect of Aprepitant and Dxamethasone on nausea and vomiting induced by high-emetic-risk chemotherapy in patients. - PROEMEND
Osaka Medical College Hospital0 个研究点目标入组 200 人开始时间: 2013年5月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Patients during pimozide administration (2)Patients who has severe liver failure or renal failure (3)Patients who enforced high- or moderate-emetic-risk chemotherapy in the past (4)Patients who has vomited or provoed nausea in the 24 hours prior to start of chemotherapy (5)Patients who is considered inappropriate as a target patient by a physician-in-charge
研究者
相似试验
已完成
不适用
Evaluation of combinational effect of Aprepitant on nausea and vomiting induced by chemotherapy (moderate risk) in patients with Gastric Cancer or Colorectal CancerInoperable advanced/recurrence Gastric Cancer or Colorectal CancerJPRN-UMIN000008041Osaka Medical College Hospital100
招募中
3 期
Evaluation of the efficacy of Aprepitant in vomiting of children with cancerMalignant cancer.Agranulocytosis secondary to cancer chemotherapyD70.1IRCT20200204046377N1Shahid Beheshti University of Medical Sciences30
尚未招募
3 期
A study to assess the competency of drugs between ondansetron and aprepitant in preventing patient with post surgical nausea and vomiting.CTRI/2023/07/055093Dr. Sathya priya
已完成
3 期
efficacy of adding Aprepitant into antiemesis prophylactic regimen in nausea and vomiting of moderate emetogenic regimeCondition 1: nausea and vomiting. Condition 2: adverse reaction.Nausea with vomiting, unspecifiedPoisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classifiedR11.2IRCT20191103045317N1Shahid Beheshti University of Medical Sciences90
尚未招募
4 期
Comparison between two different antiemetic regimens in patients treated with concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer : A Randomized, Double Blind, Controlled Clinical TrialCTRI/2024/06/068878Pt BD Sharma UHS Rohtak